Solexin

Quick links to important sections

Solexin

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solexin

Property Description
Active ingredient Cephalexin
Form Capsules, Tablets, Oral Suspension
Pharmacological Class First-Generation Cephalosporin Antibiotic
General Purpose Treatment of susceptible bacterial infections
Origin Semisynthetic

What Type of Medicine is Solexin?

Solexin is a prescription-only medicine that functions as a systemic anti-infective agent used to eliminate susceptible bacterial infections throughout the body. Its active component, Cephalexin, firmly establishes the drug within the cephalosporin class of antibiotics. This classification is specific, as Cephalexin is formally recognized as a first-generation cephalosporin, which refers to its profile as one of the earliest agents in this chemical family. This class of antibiotics is used to manage common bacterial infections, which is an established role in antimicrobial therapy.


Cephalexin: Composition, Form, and Semisynthetic Origin

The composition of Solexin is based on the single active substance, Cephalexin, a compound characterized by its semisynthetic origin. This means the substance is chemically derived from natural precursors but then modified in a laboratory setting to enhance its stability and overall effectiveness. The clinical profile of Cephalexin includes efficacy against common Gram-positive bacterial strains. For oral administration, Solexin is made available in several dosage forms, including traditional capsules and tablets, as well as a powder for oral suspension. The availability of the oral suspension is often a differentiating factor, positioned for use in the pediatric patient group. This variety ensures flexibility in therapy.


How Does Solexin Function at a Fundamental Level?

Solexin is defined as a bactericidal agent, meaning its fundamental function is to actively kill susceptible bacteria by causing the collapse of their structural integrity. This occurs through a specialized process of disrupting the bacteria’s cell wall synthesis. This specific action is a feature of the beta-lactam class to which cephalosporins belong, and this mechanism is a recognized method for the systemic resolution of bacterial infections. In typical use, the medicine targets pathogens that might cause common issues requiring an antibiotic, such as infections of the skin or respiratory tract.

Regulatory References

  1. FDA/NIH DailyMed Label
  2. NIH/StatPearls Cephalosporin Mechanism

What side effects are possible with Solexin?

Possible Side Effects and Safety Information

Solexin is an antibiotic, and its safety profile is defined by both common gastrointestinal disturbances and the risk of serious, systemic adverse reactions.

Documented Adverse Reactions

The most commonly reported side effects typically involve the Gastrointestinal System and include diarrhea, nausea, vomiting, abdominal pain, and indigestion. These are generally mild and temporary, often resolving as the body adjusts to the medication. Skin rash is also a common side effect.

Less common but documented adverse reactions include headache, dizziness, loss of appetite, and joint pain.

System-Organ Class Key Adverse Reactions (Common)
Gastrointestinal Disorders Diarrhea, Nausea, Vomiting, Abdominal pain, Indigestion
Infections and Infestations Vaginal yeast infection, Oral thrush
Skin and Subcutaneous Tissue Disorders Rash, Itching

Serious and Clinically Significant Safety Concerns

Immediate medical attention is necessary if signs of severe allergic reaction (anaphylaxis) occur. These rare but serious reactions may present as severe rash, hives, swelling of the face, tongue, or throat, and difficulty breathing. Serious skin reactions, such as blistering or peeling, are also rare but warrant immediate discontinuation of the medication.

Other serious risks include:

  • Severe or persistent diarrhea which may be a sign of a more serious gut infection, such as Clostridium difficile-associated diarrhea.
  • Liver problems, indicated by symptoms like yellowing of the skin or eyes (jaundice), dark urine, or pale stools.
  • Kidney damage or worsening of existing kidney impairment.

Population-Specific Safety Considerations

The use of Solexin in patients with a history of severe kidney disease requires caution and potential dose adjustment. Similarly, patients with a history of gastrointestinal diseases, particularly colitis, should use this drug with care as it may worsen their condition. The drug is known to pass into breast milk, and monitoring for effects in nursing infants, such as diarrhea or oral thrush, is advised.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of Solexin (Cephalexin) details the documented clinical manifestations and the required immediate emergency actions.

Overdose may initially present with common gastrointestinal effects, including nausea, vomiting, epigastric distress, and diarrhea. A less common but documented manifestation is hematuria (blood in the urine). The most severe outcome is the potential for seizures or convulsions, a risk particularly noted in patients with markedly impaired renal function if the standard dosage was not reduced.

Overdose Classification Official Regulatory Statement
Antidote Status No specific antidote is established.
Management General supportive measures are recommended.
Non-Established Procedures Benefits of procedures like hemodialysis are not confirmed.

When Immediate Medical Help is Required

For any suspected overdose, it is mandated to seek immediate medical attention. Immediate contact with emergency services (e.g., 911) or a Poison Control Center is required when severe, life-threatening symptoms are present, such as loss of consciousness (cannot be awakened), difficulty breathing, or the occurrence of a seizure. Careful clinical observation and laboratory studies are specifically recommended when managing overdose in patients with pre-existing renal impairment.

Therapeutic Uses of Solexin

What Solexin Treats: Main Uses and Benefits

Solexin is a compound primarily indicated for use in managing symptoms associated with certain chronic inflammatory conditions. This compound is part of a treatment plan to support the management of discomfort and swelling related to these domains. It assists in maintaining patient comfort levels and may contribute to improved daily functioning for those affected by long-term inflammatory responses.

Quick Facts

  • Indicated for use in chronic inflammatory conditions.
  • May support the management of discomfort and swelling.
  • Assists in maintaining patient comfort.

Solexin is also investigated for its role in supporting therapeutic outcomes for individuals experiencing pain associated with specific neuropathic conditions. The compound may be used to help manage the intensity of discomfort and contribute to a patient's overall well-being. Treatment decisions should always be made in consultation with a qualified healthcare professional, who can provide therapeutic guidance and approved uses based on the specific condition and patient needs. The goal of treatment with Solexin is to support the reduction of symptom severity in the approved patient populations.

Eligibility and Restrictions for Use

Who can and cannot use Solexin?

This section outlines the official eligibility and non-eligibility rules for Solexin as established by government regulatory agencies.


Eligibility Scope

Classification Rule
Populations for whom use is Contraindicated Individuals with known allergy or hypersensitivity to Solexin, any other cephalosporin antibiotic, or who have a severe penicillin allergy (due to risk of cross-hypersensitivity).
Age-related Eligibility Rules Use is established in adults. In pediatric patients (under 1 year of age), safety and efficacy are often not established, restricting use.
Condition-specific Eligibility Rules Patients with impaired renal function require specific dose adjustments and careful monitoring as mandated by the label. Caution is required in patients with a history of gastrointestinal disease, particularly colitis.
Pregnancy and Lactation Eligibility Use during pregnancy is generally advised only if clearly needed. The drug is excreted in breast milk in low concentrations, requiring caution in nursing mothers.

Official Regulatory Basis

The official eligibility profile is defined by the Contraindications and Warnings/Precautions sections of the regulatory labeling. These statements dictate that individuals must not use the medicine if they fall into an excluded group (absolute contraindication) or must be managed with conditional use if they have specific organ impairment or are in a special physiological state.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Solexin (Secnidazole, a nitroimidazole antimicrobial) details several required avoidance constraints to prevent potential interaction-related adverse effects.

Interaction Constraints and Conditions

Interaction Domain Practical Regulatory Restriction
Ethanol and Propylene Glycol Avoid consumption of alcoholic beverages and preparations containing ethanol or propylene glycol during treatment and for at least 2 days after therapy completion.
Nitroimidazole Derivatives Contraindicated in patients with Cockayne syndrome due to reports of severe irreversible liver failure with related nitroimidazole drugs like metronidazole.
Oral Contraceptives Official data indicates no clinically significant interaction with combined oral contraceptives (ethinyl estradiol plus norethindrone); co-administration is permitted.

Official Interaction Statements

  • Alcoholic beverages and preparations containing ethanol or propylene glycol must be avoided during therapy and for 48 hours after the final dose. Concomitant use has been associated with reported adverse reactions.
  • The product is contraindicated in individuals with Cockayne syndrome.

This interaction profile is primarily structured around mandatory time-sensitive avoidance rules for specific consumables and a condition-specific prohibition (contraindication) linked to a known class risk for severe liver injury.

Mechanism of Action

️ How Solexin Works

Irreversible Blockade of Bacterial Cell Wall Assembly

The core mechanism of Solexin (Cephalexin) is the irreversible inhibition of Penicillin-Binding Proteins (PBPs), bacterial enzymes (transpeptidases) integral to cell viability. By forming a covalent bond with the active site, the drug prevents the final step of peptidoglycan cross-linking, immediately halting the assembly of the bacterial cell wall structure.


Inducing Osmotic Lysis: The Bactericidal Cascade

This inhibition initiates a lethal bactericidal cascade. Without the structural support of a properly formed cell wall, the bacterial cell cannot withstand its internal high pressure (turgor). This leads to an acute osmotic imbalance, causing the cell membrane to rupture (cell lysis). This physiological consequence results in the death of the susceptible bacterial organism.


Constraints on Mechanistic Efficacy

The action is subject to biological constraints, being less effective against bacteria that produce beta-lactamase enzymes (which chemically inactivate the drug) or those with modified PBPs (reduced binding affinity). Furthermore, the bactericidal effect is most pronounced only when bacteria are actively dividing.

Dosage and Administration Information

How to Use Solexin

The use of Solexin (Cephalexin) is guided by instructions that standardize administration, dosing frequency, and required course duration.


Administration Scope

Field Standard Instruction
Route of administration Oral administration only, available as capsules, tablets, or oral suspension.
Dosing schedule Usual adult dose is 250 mg every 6 hours or 500 mg every 12 hours. The total daily dose is 1 g to a maximum of 4 g, administered in equally divided portions.
Timing in relation to meals May be administered without regard to meals as the medicine is acid-stable.
Preparation requirements The Powder for Oral Suspension requires reconstitution with water and must be shaken well before each use.
Age-group rules Pediatric (over 1 year): 25 to 50 mg/kg/day in divided doses. Renal Impairment: Dose reduction is required for adults with a Creatinine Clearance below 30 mL/min.
Missed-dose rules If a dose is missed, take it as soon as remembered. If it is almost time for the next dose, skip the missed dose and continue the regular schedule. Do not double the dose.
Special procedural conditions The medicine must be continued for the full prescribed duration, typically 7 to 14 days, and a minimum of 10 days for infections caused by beta-hemolytic streptococci.

Instruction Classifications (High-Level)

Field Classification
Administration method type Oral
Frequency pattern Divided use (typically two or four times daily).
Basis of use Established pharmaceutical standards.
Use-context constraints Fixed duration requirement; weight-based dosing; renal function dependent dose adjustments.

Resulting Procedural Structure

Standard step sequence:

  • 1. Administer the prescribed dose at the fixed interval (e.g., every 6 or 12 hours) to maintain consistent systemic levels.
  • 2. Ensure the liquid suspension is properly reconstituted and shaken before being measured with a dedicated device.
  • 3. Complete the entire treatment course as specified in the duration guidelines.

Connection to the overall use protocol: These instructions create a structured, standardized protocol for administration, defining the required oral route, the fixed intervals for dosing, and the modifications for impaired kidney function. This structure ensures the medicine is used procedurally correct, independent of the clinical condition being addressed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Solexin

Evidence for Use in Acute Bacterial Infections

This section summarizes the types of foundational studies, primarily Randomized Controlled Trials (RCTs) and comparative pharmacological research, that was studied for use in infections caused by susceptible bacteria, such as those affecting the skin or respiratory tract.

Research examined the use of Solexin in acute bacterial infections. Studies explored how the medicine works against specific types of bacteria that may cause common issues. These studies primarily focused on outcomes describing episodic or acute changes, using specific criteria to examine symptom intensity or variability. This type of research contributes to the broader evidence landscape.

Research on Clinical Outcomes and Bacteriological Measures

The main measures studied for Solexin included patient-reported outcomes describing perceived discomfort and measures of systemic or functional imbalance. Specifically, researchers examined clinical endpoints, which monitored changes in symptoms, and also assessed bacteriological outcomes, which determined if the targeted bacteria were cleared. This dual approach helps contextualize what the research explored.

Evidence in Special Populations

Solexin was studied for use in the pediatric patient group, which is reflected in its availability in formulations like powder for oral suspension. Studies explored the patterns of change in children with acute infections, tracking their clinical response over short-term periods. This evidence contributes to understanding symptom patterns in this population.

Conversely, data for certain groups remain insufficient or evidence quality varies across studies. For instance, there is limited information for long-term outcomes in older adult populations, or in patients with significant underlying systemic or functional imbalance. Research in these specific, complex subgroups appears to be less extensive than in the general adult and pediatric populations, meaning subgroup findings are uncertain.

Evidence Quality, Consistency, and Uncertainty

The research for Solexin is supported by a high level of evidence, reflecting its status as one of the earlier agents in its class. Research describes consistency across many fundamental studies.

Follow-up durations were limited in many primary trials. Furthermore, the results apply only to the populations studied, which may exclude individuals with complex health issues. Ongoing research is examining how the drug's activity relates to the continuous evolution of antibiotic resistance, particularly concerning certain common pathogens. This remains an area of uncertainty, and the patterns of outcomes related to systemic or functional imbalance can vary based on regional resistance.

Frequently Asked Questions (FAQ)

Common questions about Solexin (FAQ)

Q: How quickly should I expect to see an effect from Solexin?

A: Official human pharmacology studies indicate that the medicine is rapidly absorbed after being taken by mouth. The drug typically reaches its highest levels in the bloodstream approximately one hour after dosing. This indicates that the active substance becomes available to the body relatively quickly after it is taken.

Q: Does Solexin interact with common over-the-counter pain relievers?

A: Regulatory documents do not typically list specific interactions with common over-the-counter pain relievers, such as acetaminophen or ibuprofen. However, some sources suggest that careful monitoring may be needed when combining Solexin with certain nonsteroidal anti-inflammatory drugs (NSAIDs) due to a possible impact on the kidneys.

Q: Are there any documented interactions between Solexin and herbal supplements?

A: Official drug labels do not routinely list every possible interaction with herbal supplements. However, one specific interaction noted in authoritative sources is the potential for zinc supplements to reduce the amount of Solexin absorbed by the body. General product information may suggest separating doses, such as a 3-hour gap, if using zinc supplements.

Q: Are there any known interactions between Solexin and alcohol?

A: Official instructions for the active ingredient in Solexin generally state that it can be consumed with alcohol. Unlike some other antibiotics, an avoidance rule is typically not required. Specific patient information should always be reviewed for individual guidance.

Q: Is it normal to feel more tired when starting Solexin?

A: Official adverse reaction reports and safety documents list fatigue, which is a feeling of tiredness, among the documented side effects. Other central nervous system effects reported include dizziness and headache. These effects are often reported as temporary while the body adjusts to the medicine.

Q: What happens if I stop taking Solexin suddenly without talking to my doctor?

A: Official guidance advises that the medicine must be taken exactly as directed and that the full prescribed course should be completed. Discontinuing the medication early may not fully eliminate the bacteria causing the infection. Regulatory guidance emphasizes completing the full course to help manage the risk of the infection recurring or contributing to drug resistance.

Q: Can Solexin be crushed, split, or chewed, or must it be swallowed whole?

A: For the solid forms of this medicine, such as capsules and tablets, instructions often advise swallowing them whole with a drink of water. Patients are typically advised not to chew, split, or crush the solid dosage forms unless a healthcare professional specifically advises otherwise.

Q: Do I need to take Solexin with food, or can I take it on an empty stomach?

A: According to the official prescribing information, Solexin is an acid-stable medicine, meaning it is not affected by stomach acid. Therefore, it may be administered without regard to meals, and administration is permitted either with food or on an empty stomach.

Q: How long does Solexin typically stay in your system after stopping it?

A: Studies on human pharmacology show that in a person with normal kidney function, the drug has a short half-life, which is less than one hour. This means the body processes the drug relatively quickly, with over 90% of the unchanged dose typically being excreted in the urine within about eight hours.

Q: Are there any different forms of Solexin (e.g., tablet, liquid, extended-release)?

A: Official product information states that the drug is available in several high-level dosage forms, including capsules, tablets, and a powder that is mixed with water to create an oral suspension (liquid). Official labels list these forms, but do not list an extended-release form of this medicine.

Q: What is the purpose of the different strengths or dosages Solexin comes in?

A: The medicine is available in various strengths, such as 250 mg and 500 mg. These different dosages are used to ensure the appropriate total daily amount and frequency is given for different types of infections, their severity, and specific patient needs, such as body weight in children or kidney function in adults.

Q: Does Solexin have any known effects on mental health or mood?

A: While not common, official adverse reaction lists do mention potential effects on the central nervous system. These documented effects include, in rare instances, symptoms such as confusion, agitation, nervousness, and hallucinations.

Q: What is the typical timeframe people are prescribed Solexin for?

A: According to official regulatory instructions for use, the overall duration of treatment is typically between 7 and 14 days. The exact timeframe depends on the specific type and severity of the infection being addressed. A minimum of 10 days is typically recommended for infections caused by certain types of streptococci bacteria.

Q: Is Solexin known to cause weight gain or weight loss?

A: Weight change is not listed as one of the common or rare adverse reactions in the main safety information contained in the official regulatory documents for the drug.

Q: Is Solexin considered a controlled substance?

A: No. The active ingredient in Solexin is an antibiotic and is not classified as a controlled substance under government drug control acts. It is, however, a prescription-only medicine.

Q: Is Solexin the same type of drug as other common treatments in this category?

A: Solexin belongs to the cephalosporin class of antibiotics. This class is defined by its chemical structure, which is related to the penicillin class of antibiotics. This places it in the larger category of beta-lactam antimicrobials.

Q: I heard Solexin has a 'Black Box' warning—what does that mean in simple terms?

A: The official Food and Drug Administration (FDA) label for the active ingredient in Solexin does not contain a Black Box Warning. This is the highest level of warning the FDA uses; its absence on Solexin’s label indicates the drug does not carry this specific, serious risk designation.

Q: Do people usually stop taking Solexin abruptly, or is a tapering process described?

A: Official instructions focus on the importance of completing the full prescribed duration of therapy. Unlike some other medicines, official guidance does not generally describe a specific tapering process; patients are typically instructed to complete the course and then stop.

Q: Is there a generic version of Solexin available?

A: Yes, the generic version of the medicine, known by its active ingredient Cephalexin, is widely available. The availability of a generic version is noted in government pharmaceutical databases.

Q: Is Solexin a habit-forming medicine?

A: No. Solexin is an antibiotic and is not classified as a controlled substance. Official regulatory literature does not list dependence or habit formation as a risk or side effect associated with the use of this medicine.

How should Solexin be stored and disposed of?

Storage and Disposal of Solexin

Storage requirements for Solexin are defined by dosage form to maintain product quality.

️ Storage Conditions

Solexin capsules and tablets must be stored at a Controlled Room Temperature between 20 C and 25 C (68 F and 77 F). All solid forms must be kept in the original container, which must be tightly closed to protect the contents from light and moisture.

For the oral suspension, the product must be stored in a refrigerator (2 C to 8 C) after mixing and must not be frozen. Any unused portion of the reconstituted suspension must be discarded after 14 days.

All forms of Solexin must be kept out of the sight and reach of children.

️ Disposal Instructions

Expired or unused Solexin must be disposed of according to local regulations. The product should not be flushed down the toilet or poured down a drain. If a drug take-back program is unavailable, the medication should be mixed with an unappealing substance, sealed in a bag, and placed in the household trash, with personal information removed from the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Solexin found in:

A-Z Index: